Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.9600 (7.09%) ($13.9700 - $15.5300) on Wed. Feb. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.31% (three month average) | RSI | 33 | Latest Price | $14.9600(7.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.7% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(49%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.655% in a week (0% probabilities). VIXM(-37%) VXX(-36%) TLT(-11%) UNG(-7%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.655% (StdDev 3.31%) | Hourly BBV | 0 () | Intraday Trend | 5.6% | | | |
|
5 Day Moving Average | $13.91(7.55%) | 10 Day Moving Average | $13.88(7.78%) | 20 Day Moving Average | $14.92(0.27%) | To recent high | -15.9% | To recent low | 23% | Market Cap | $1.112b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |